Jan 25 (Reuters) - Amylin Pharmaceuticals Inc:
* Icahn Capital says Amylin Pharmaceuticals assured that sufficient number of
board members will vote to re-nominate 12 incumbent directors
* Icahn Capital says Amylin Pharma assured incumbents Alexander
Ddenner, Kathleen Behrens to be re-nominated - filing
* Icahn Capital says believes Amylin Pharma board is functioning more
satisfactorily than in the past
* Icahn Capital says has determined not to give notice of intent to nominate
persons for election to Amylin board
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Icahn Capital says Amylin Pharmaceuticals assured that sufficient number of
board members will vote to re-nominate 12 incumbent directors
* Icahn Capital says Amylin Pharma assured incumbents Alexander
Ddenner, Kathleen Behrens to be re-nominated - filing
* Icahn Capital says believes Amylin Pharma board is functioning more
satisfactorily than in the past
* Icahn Capital says has determined not to give notice of intent to nominate
persons for election to Amylin board
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.